adesso SE

Informe acción XTRA:ADN1

Capitalización de mercado: €414.5m

adesso Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Los beneficios de adesso han disminuido a una tasa media anual de -43.3%, mientras que en la industria IT los beneficios crecieron en un 6.1% anualmente. Los ingresos han ido creciendo a una tasa media de 19% al año. La rentabilidad financiera de adesso es de 14%, y sus márgenes netos son de 1.8%.

Información clave

-43.28%

Tasa de crecimiento de los beneficios

-44.10%

Tasa de crecimiento del BPA

Crecimiento de la industria IT 13.97%
Tasa de crecimiento de los ingresos19.01%
Rentabilidad financiera13.99%
Margen neto1.77%
Próxima actualización de resultados14 Aug 2026

Actualizaciones de resultados anteriores recientes

Artículo de análisis Apr 07

Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality

When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...

Recent updates

Actualización de narrativa May 23

ADN1: 2026 Guidance And Dividend Outlook Will Support Future Upside Potential

Analysts have trimmed their price target for adesso from about €107.67 to about €103.33, pointing to shifts in model assumptions around the discount rate, revenue growth, profit margins and future P/E as the key drivers behind the change. What's in the News adesso SE reaffirmed its earnings guidance for fiscal 2026, citing sustained demand for digitalisation projects despite the German government assessing weaker recovery trends for the German economy in 2026, particularly linked to energy prices (Corporate Guidance).
Actualización de narrativa May 09

ADN1: 2026 Earnings Guidance And Dividend Policy Will Support Future Upside Potential

Analysts have reduced their price target on adesso from €114.17 to €107.67, citing slightly revised revenue growth and P/E assumptions along with a modestly higher profit margin outlook. What's in the News adesso reaffirmed earnings guidance for 2026, with expected revenues in a range of €1.6b to €1.7b and guidance that EBIT margin is expected to show only a little improvement in 2026 (Corporate Guidance).
Actualización de narrativa Apr 24

ADN1: Higher Discount Rate Will Create Long Term Opportunity

Analysts have reduced their price target on adesso from €160 to €140, citing updated assumptions for a higher discount rate, slightly lower revenue growth and profit margin expectations, and a higher future P/E multiple. What's in the News adesso SE reaffirmed earnings guidance for 2026, with expected revenues in a range between €1.6b and €1.7b and only a little improvement in the EBIT margin in that year (Corporate Guidance).
Actualización de narrativa Apr 10

ADN1: Dividend Visibility And Expanded Partnership Will Support Future Upside Potential

Analysts have trimmed their price target for adesso from about €127.83 to about €114.17. They now apply a higher discount rate, slightly lower revenue growth and profit margin assumptions, and a higher future P/E multiple in their models.
Artículo de análisis Apr 07

Shareholders Can Be Confident That adesso's (ETR:ADN1) Earnings Are High Quality

When companies post strong earnings, the stock generally performs well, just like adesso SE's ( ETR:ADN1 ) stock has...
Artículo de análisis Feb 12

The Price Is Right For adesso SE (ETR:ADN1) Even After Diving 28%

The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 28%. Instead...
Artículo de análisis Jan 22

adesso (ETR:ADN1) Seems To Use Debt Quite Sensibly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Artículo de análisis Oct 19

Is There Now An Opportunity In adesso SE (ETR:ADN1)?

adesso SE ( ETR:ADN1 ), is not the largest company out there, but it saw a significant share price rise of 23% in the...
Artículo de análisis Sep 12

A Piece Of The Puzzle Missing From adesso SE's (ETR:ADN1) 32% Share Price Climb

adesso SE ( ETR:ADN1 ) shareholders would be excited to see that the share price has had a great month, posting a 32...
Artículo de análisis Sep 10

Here's What's Concerning About adesso's (ETR:ADN1) Returns On Capital

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Artículo de análisis May 25

Solid Earnings Reflect adesso's (ETR:ADN1) Strength As A Business

adesso SE's ( ETR:ADN1 ) earnings announcement last week was disappointing for investors, despite the decent profit...
Artículo de análisis Feb 25

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.75

The board of adesso SE ( ETR:ADN1 ) has announced that the dividend on 6th of June will be increased to €0.75, which...
User avatar
Nueva narrativa Feb 07

Ongoing IT Investments Will Transform Operations By Mid-2025

Organic growth in healthcare and utilities drives future revenue, overcoming economic challenges, while strategic share buybacks reflect belief in undervaluation.
Artículo de análisis Dec 02

Investors Still Aren't Entirely Convinced By adesso SE's (ETR:ADN1) Revenues Despite 32% Price Jump

adesso SE ( ETR:ADN1 ) shares have continued their recent momentum with a 32% gain in the last month alone. Not all...
Artículo de análisis Nov 22

adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Investors signalled that they were pleased with adesso SE's ( ETR:ADN1 ) most recent earnings report. Looking deeper at...
Artículo de análisis Nov 17

adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target

The investors in adesso SE 's ( ETR:ADN1 ) will be rubbing their hands together with glee today, after the share price...
Artículo de análisis Nov 02

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Artículo de análisis Aug 28

It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks

The adesso SE ( ETR:ADN1 ) share price has fared very poorly over the last month, falling by a substantial 25%. Instead...
Artículo de análisis May 21

adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year

The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...
Artículo de análisis Apr 19

adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70

The board of adesso SE ( ETR:ADN1 ) has announced that it will be paying its dividend of €0.70 on the 7th of June, an...
Artículo de análisis Apr 18

Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Artículo de análisis Apr 02

Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality

The market for adesso SE's ( ETR:ADN1 ) shares didn't move much after it posted weak earnings recently. We did some...
Artículo de análisis Mar 28

Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results

Last week saw the newest full-year earnings release from adesso SE ( ETR:ADN1 ), an important milestone in the...
Artículo de análisis Mar 23

Is adesso SE (ETR:ADN1) Trading At A 44% Discount?

Key Insights adesso's estimated fair value is €193 based on 2 Stage Free Cash Flow to Equity Current share price of...
Artículo de análisis Mar 08

adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward

adesso SE ( ETR:ADN1 ) shares have had a really impressive month, gaining 29% after a shaky period beforehand. Not all...
Artículo de análisis Dec 14

A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)

Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €95.16 With €91.00 share price...
Artículo de análisis Oct 11

Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Artículo de análisis Jul 22

At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?

adesso SE ( ETR:ADN1 ), might not be a large cap stock, but it received a lot of attention from a substantial price...
Artículo de análisis Jun 15

Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)

Key Insights Using the 2 Stage Free Cash Flow to Equity, adesso fair value estimate is €146 With €123 share price...
Artículo de análisis May 09

adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
Artículo de análisis Apr 22

What Does adesso SE's (ETR:ADN1) Share Price Indicate?

While adesso SE ( ETR:ADN1 ) might not be the most widely known stock at the moment, it saw significant share price...
Artículo de análisis Feb 11

adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Artículo de análisis Jan 26

Returns On Capital At adesso (ETR:ADN1) Have Stalled

If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...

Desglose de ingresos y gastos

Cómo gana y gasta dinero adesso. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

XTRA:ADN1 Ingresos, gastos y beneficios (EUR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Mar 261,53727270
31 Dec 251,48918270
30 Sep 251,4235250
30 Jun 251,3794250
31 Mar 251,335-1250
31 Dec 241,2983250
30 Sep 241,2695200
30 Jun 241,225-1200
31 Mar 241,182-2200
31 Dec 231,1403200
30 Sep 231,0845160
30 Jun 231,03712160
31 Mar 2396918160
31 Dec 2290129160
30 Sep 2283629110
30 Jun 2276928110
31 Mar 2272537110
31 Dec 2167848110
30 Sep 216364590
30 Jun 216004690
31 Mar 215644290
31 Dec 205242190
30 Sep 205032440
30 Jun 204841990
31 Mar 204671890
31 Dec 194511790
30 Sep 1943215110
30 Jun 1941213140
31 Mar 1939513140
31 Dec 1837814140
30 Sep 1836414140
30 Jun 1835114140
31 Mar 1833613140
31 Dec 1732211140
30 Sep 1730711130
30 Jun 1729211120
31 Mar 1727612120
31 Dec 1626112120
30 Sep 1624510100
30 Jun 16229790
31 Mar 16213690
31 Dec 15197590
30 Sep 15183470
30 Jun 15169440

Ingresos de calidad: ADN1 tiene ganancias de alta calidad.

Margen de beneficios creciente: ADN1 pasó a ser rentable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: Los beneficios de ADN1 han disminuido en un 43.3% al año en los últimos 5 años.

Acelerando crecimiento: ADN1 ha pasado a ser rentable en el último año, lo que dificulta la comparación de la tasa de crecimiento de los beneficios con su promedio de 5 años.

Beneficios vs. Industria: ADN1 ha pasado a ser rentable en el último año, lo que es difícil comparar el crecimiento de sus beneficios en el último año con el de la industria IT (4%).


Rentabilidad financiera

Alta ROE: La rentabilidad financiera de ADN1 (14%) se considera baja.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/06/01 23:41
Precio de las acciones al final del día2026/06/01 00:00
Beneficios2026/03/31
Ingresos anuales2025/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

adesso SE está cubierta por 11 analistas. 6 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Daniel GroßjohannBankM AG
Wolfgang SpechtBerenberg
Finn KemperHauck Aufhäuser Investment Banking